Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58.6M
-
Number of holders
-
168
-
Total 13F shares, excl. options
-
65.2M
-
Shares change
-
+364K
-
Total reported value, excl. options
-
$3.37B
-
Value change
-
+$56.1M
-
Put/Call ratio
-
0.63
-
Number of buys
-
74
-
Number of sells
-
-103
-
Price
-
$51.64
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q1 2021
226 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock as of Q1 2021.
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) has 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.2M shares
.
Largest 10 shareholders include FMR LLC (7.88M shares), WELLINGTON MANAGEMENT GROUP LLP (6.85M shares), VANGUARD GROUP INC (5.73M shares), BlackRock Inc. (4.68M shares), Bellevue Group AG (4.54M shares), JPMORGAN CHASE & CO (3.37M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.96M shares), Rock Springs Capital Management LP (2.54M shares), Casdin Capital, LLC (2.17M shares), and STATE STREET CORP (1.73M shares).
This table shows the top 168 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.